Key indicators: single-crystal X-ray study; T = 173 K; mean (C-C) = 0.009 Å; R factor = 0.038; wR factor = 0.048; data-to-parameter ratio = 15.3.
In the title compound, [Cu(C 17 H 30 N 2 O 2 )(C 3 H 7 NO) 2 ][SbF 6 ] 2 , which is a potential catalyst in the asymmetric Gosteli-Claisen rearrangement, the Cu atom adopts a distorted cis-CuN 2 O 2 square-planar geometry arising from N,N 0 -bidentate coordination by the chiral ligand and two O-bonded dimethylformamide molecules. Two short C-HÁ Á ÁO contacts occur within the ligand and two weak intermolecular C-HÁ Á ÁF bonds may help to establish the packing.
Related literature
For further synthetic details, see: Evans et al. (1981 Evans et al. ( , 1999 ; Meyers & McKennon (1993) . For information on the catalytic properties of the title compound, see: Abraham et al. ( , 2004 ; ; Hiersemann & Abraham (2002) .
Experimental
Crystal data [Cu(C 17 Hydrogen-bond geometry (Å , ). Data collection: CrysAlis CCD (Oxford Diffraction, 2008 ); cell refinement: CrysAlis CCD; data reduction: CrysAlis RED (Oxford Diffraction, 2008); program(s) used to solve structure: SHELXS97 (Sheldrick, 2008 ); program(s) used to refine structure: SHELXL97 (Sheldrick, 2008) ; molecular graphics: SHELXTL-Plus (Sheldrick, 2008) ; software used to prepare material for publication: SHELXL97 and PLATON (Spek, 2009 Hiersemann & Abraham, 2002; Abraham et al., 2004) . The synthesis of the title compound, (I), was accomplished according to a modified procedure of Evans et al. (1999) . A sequence of Meyer's amino acid reduction of (S)-tert-Leucine (Meyers & McKennon, 1993) , subsequent condensation with dimethyl malonic acid dichloride and p-TsCl catalyzed cyclization provided the (S,S)-t-Bu-box ligand. Treatment of the box ligand with CuCl 2 (Evans et al., 1981) Fig. 1 . The molecular structure of (I) with displacement ellipsoids shown at the 30% probability level.
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